Chief Editor and Editors play a vital role in maintaining standards of the journal through a peer review process. Editors should make sure that all the articles must be published concerning the scope of the journal according to scientific relevancy, veracity, research strength, innovative methods. Editors must be unbiased with his/her decisions given on manuscripts and that should not be affected by the author’s nativity, nationality, ethnicity, religion, etc. Manuscript judgment must support the logical strength and significance to the scientific world.
Responsibilities
After receiving manuscripts from the author, the editorial office assigns the manuscript to an editor to review the manuscript. Papers are assigned to editors based on their expertise and research interest. The editor’s role is to assign two reviewers to provide review comments. In a situation where the editor cannot assign reviewers, then the editorial office assigns the reviewers on behalf of the editor. The editor should respond timely on his/her timeline in completing the peer review process and providing his/her decisions on manuscripts. The editor has to supervise the entire peer review cycle to preserve the principles of the journal. The editor can handle any number of manuscripts for the peer review process according to his interest and other commitments. As the editors are back bone to journal sustainability, editors can contribute the manuscripts which can be research articles/ editorials/ short communications for the continuation of issues in the journal. The editor has to encourage the submissions from other qualified authors, and they can suggest their colleagues. We welcome our editors to suggest new thoughts and ideas for the advancement of the journal. Editors need to ensure the security of individual data and maintain privacy.
Published : 01st April 2024
Author : Marjan Dzeparoski1,2,*
Citation : Dzeparoski M. (2024). Regulatory Update on eSubmissions in Balkans. Mathews J Pharma Sci. 8(1):26.
Published : 11th December 2023
Authors : Aria Hajihassan1, Atena Zandi1, Ghazal Esmaeili1, Mostafa Norizadeh2,3,*
Citation : Hajihassan A, et al. (2023). Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews J Pharma Sci. 7(4):25.
Published : 25th November 2023
Authors : Qadeer Ahmed, Muhammad Talha, Umer Ishtiaq, Saba Khurshid, Kaif Akbar, Urwa Amir, Muhammad Rehan, Ovais Ullah Shirazi, Shahid Latif, Zunaira Akbar, Iram Batool, Ali Akhtar*, Samreen Fatima
Citation : Ahmed Q, et al. (2023). Quality of Life and Medication Adherence in Rheumatoid Arthritis Patients. Mathews J Pharma Sci. 7(4):24.
Published : 03rd November 2023
Authors : Dadier Antonio Arroyo1,2,*, Linda Atencio1, Jorge Pérez Velásquez3, María Camila Coronado1, Meribeth Henry4, Maria Alejandra Suarez2, Daniela Katerine Rivera2
Citation : Arroyo DA, et al. (2023). Desensitization in a Patient with Hypersensitivity to the Iodinated Contrast Medium Iopromide: A Clinical Case Report. Mathews J Pharma Sci. 7(3):23.
Published : 17th October 2023
Author : Raúl Isea*
Citation : Isea R. (2023). We Continue to Battle with Diseases that are Difficult to Diagnose and Cure in the 21st Century. Mathews J Pharma Sci. 7(3):22.
Published : 11th October 2023
Authors : Allen B Richon1,*, Merry Ambos Richon2
Citation : Richon AB, et al. (2023). Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews J Pharma Sci. 7(3):21.